Comparison of Prognostic Value of Tissue Doppler Imaging in Carcinoid Heart Disease Versus the Value in Patients With the Carcinoid Syndrome but Without Carcinoid Heart Disease

American Journal of Cardiology

Volumn 105, Issue 4, 2010, Pages 527-531

  Mansencal, Nicolas ^a   McKenna, William J ^d   Mitry, Emmanuel ^c   Beauchet, Alain ^b   Pellerin, Denis ^d   Rougier, Philippe ^c   Dubourg, Olivier ^a  

^a Centre Associe au Centre de Reference pour les Maladies Cardiaques Hereditaires   (France)

^b LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

^c HÔPITAL AMBROISE PARÉ   (France)

^d UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CONTRAST MEDIUM; SOMATOSTATIN DERIVATIVE;

ADULT; AGED; ARTICLE; ARTIFICIAL EMBOLISM; BLOOD FLOW VELOCITY; CARCINOID SYNDROME; CLINICAL EVALUATION; COMPARATIVE STUDY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC VALUE; DIGESTIVE ENDOCRINE TUMOR; DIGESTIVE SYSTEM TUMOR; DISEASE COURSE; DISEASE MARKER; ENDOCRINE TUMOR; FEMALE; HEPATIC ARTERY EMBOLIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL DOCUMENTATION; MITRAL VALVE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; RISK FACTOR; SENSITIVITY AND SPECIFICITY; TISSUE DOPPLER IMAGING; TUMOR LOCALIZATION; VALVULAR HEART DISEASE;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; CARCINOID HEART DISEASE; DISEASE PROGRESSION; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; FOLLOW-UP STUDIES; FRANCE; HUMANS; MALE; MALIGNANT CARCINOID SYNDROME; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SURVIVAL RATE;

EID: 75349088071     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2009.10.023     Document Type: Article

References (17)

1. Kulke M.H., and Mayer R.J. Carcinoid tumors. N Engl J Med 340 (1999) 858-868
2. Pellikka P.A., Tajik A.J., Khandheria B.K., Seward J.B., Callahan J.A., Pitot H.C., and Kvols L.K. Carcinoid heart disease. Clinical and echocardiographic spectrum in 74 patients. Circulation 87 (1993) 1188-1196
3. Mansencal N., Mitry E., Forissier J.F., Martin F., Redheuil A., Lepere C., Farcot J.C., Joseph T., Lacombe P., Rougier P., and Dubourg O. Assessment of patent foramen ovale in carcinoid heart disease. Am Heart J 151 (2006) 1129.e1-1129.e6
4. Castillo J.G., Filsoufi F., Rahmanian P.B., Anyanwu A., Zacks J.S., Warner R.R., and Adams D.H. Early and late results of valvular surgery for carcinoid heart disease. J Am Coll Cardiol 51 (2008) 1507-1509
5. Connolly H.M., Schaff H.V., Mullany C.J., Rubin J., Abel M.D., and Pellikka P.A. Surgical management of left-sided carcinoid heart disease. Circulation 104 suppl (2001) I36-I40
6. Moller J.E., Pellikka P.A., Bernheim A.M., Schaff H.V., Rubin J., and Connolly H.M. Prognosis of carcinoid heart disease: analysis of 200 cases over two decades. Circulation 112 (2005) 3320-3327
7. Ommen S.R., Nishimura R.A., Appleton C.P., Miller F.A., Oh J.K., Redfield M.M., and Tajik A.J. Clinical utility of Doppler echocardiography and tissue Doppler imaging in the estimation of left ventricular filling pressures: a comparative simultaneous Doppler-catheterization study. Circulation 102 (2000) 1788-1794
8. Yu C.M., Sanderson J.E., Marwick T.H., and Oh J.K. Tissue Doppler imaging. A new prognosticator for cardiovascular diseases. J Am Coll Cardiol 49 (2007) 1903-1914
9. Bruch C., Klem I., Breithardt G., Wichter T., and Gradaus R. Diagnostic usefulness and prognostic implications of the mitral E/E′ ratio in patients with heart failure and severe secondary mitral regurgitation. Am J Cardiol 100 (2007) 860-865
10. Mansencal N., Mitry E., Pilliere R., Lepere C., Gerardin B., Petit J., Gandjbakhch I., Rougier P., and Dubourg O. Prevalence of patent foramen ovale and usefulness of percutaneous closure device in carcinoid heart disease. Am J Cardiol 101 (2008) 1035-1038
11. Bernheim A.M., Connolly H.M., Rubin J., Moller J.E., Scott C.G., Nagorney D.M., and Pellikka P.A. Role of hepatic resection for patients with carcinoid heart disease. Mayo Clin Proc 83 (2008) 143-150
12. Connolly H.M. Carcinoid heart disease: medical and surgical considerations. Cancer Control 8 (2001) 454-460
13. Bhattacharyya S., Toumpanakis C., Caplin M.E., and Davar J. Usefulness of N-terminal pro-brain natriuretic peptide as a biomarker of the presence of carcinoid heart disease. Am J Cardiol 102 (2008) 938-942
14. Moller J.E., Connolly H.M., Rubin J., Seward J.B., Modesto K., and Pellikka P.A. Factors associated with progression of carcinoid heart disease. N Engl J Med 348 (2003) 1005-1015
15. Kerstrom G., Hellman P., and Hessman O. Midgut carcinoid tumours: surgical treatment and prognosis. Best Pract Res Clin Gastroenterol 19 (2005) 717-728
16. Bhattacharyya S., Davar J., Dreyfus G., and Caplin M.E. Carcinoid heart disease. Circulation 116 (2007) 2860-2865
17. Nagueh S.F., Appleton C.P., Gillebert T.C., Marino P.N., Oh J.K., Smiseth O.A., Waggoner A.D., Flachskampf F.A., Pellikka P.A., and Evangelista A. Recommendations for the evaluation of left ventricular diastolic function by echocardiography. J Am Soc Echocardiogr 22 (2009) 107-133